Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Intra- and Inter-tumoral Homogeneity of BRAFV600E Mutations in Melanoma Tumors.

Riveiro-Falkenbach E, Villanueva CA, Garrido MC, Ruano Y, García-Martín RM, Godoy E, Ortiz-Romero PL, Ríos-Martín JJ, Santos-Briz A, Rodríguez-Peralto JL.

J Invest Dermatol. 2015 Jun 17. doi: 10.1038/jid.2015.229. [Epub ahead of print]

PMID:
26083553
2.

Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.

Márquez-Rodas I, Martín González M, Nagore E, Gómez-Fernández C, Avilés-Izquierdo JA, Maldonado-Seral C, Soriano V, Majem-Tarruella M, Palomar V, Maseda R, Martín-Carnicero A, Puertolas T, Godoy E, Cerezuela P, Ochoa de Olza M, Campos B, Perez-Ruiz E, Soria A, Gil-Arnaiz I, Gonzalez-Cao M, Galvez E, Arance A, Belon J, de la Cruz-Merino L, Martín-Algarra S; Spanish Multidisciplinary Group of Melanoma (GEM).

PLoS One. 2015 Apr 13;10(4):e0124239. doi: 10.1371/journal.pone.0124239. eCollection 2015.

3.

[Eczematous lesions and acquired ichthyosis as a presenting finding of CD30+ anaplastic large cell lymphoma].

Sanz-Motilva V, Castellanos-González M, Martínez Sánchez P, Ortiz de Frutos J, Ortiz-Romero PL, Rodríguez-Peralto JL, Vanaclocha-Sebastián F.

Semergen. 2015 Mar 25. pii: S1138-3593(15)00071-4. doi: 10.1016/j.semerg.2015.02.010. [Epub ahead of print] Spanish. No abstract available.

PMID:
25817852
4.

MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.

Sandoval J, Díaz-Lagares A, Salgado R, Servitje O, Climent F, Ortiz-Romero PL, Pérez-Ferriols A, Garcia-Muret MP, Estrach T, Garcia M, Nonell L, Esteller M, Pujol RM, Espinet B, Gallardo F.

J Invest Dermatol. 2015 Apr;135(4):1128-37. doi: 10.1038/jid.2014.487. Epub 2014 Nov 18.

PMID:
25405321
5.

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

Martín-Sánchez E, Odqvist L, Rodríguez-Pinilla SM, Sánchez-Beato M, Roncador G, Domínguez-González B, Blanco-Aparicio C, García Collazo AM, Cantalapiedra EG, Fernández JP, Curiel del Olmo S, Pisonero H, Madureira R, Almaraz C, Mollejo M, Alves FJ, Menárguez J, González-Palacios F, Rodríguez-Peralto JL, Ortiz-Romero PL, Real FX, García JF, Bischoff JR, Piris MA.

PLoS One. 2014 Nov 11;9(11):e112148. doi: 10.1371/journal.pone.0112148. eCollection 2014.

6.

Self-healing Eyelid Nodule: A Quiz. Diagnosis: Lymphomatoid papulosis (LyP), type A.

Maroñas-Jiménez L, Menis D, Gargallo-Moneva V, Rodríguez-Peralto JL, Ortiz-Romero PL.

Acta Derm Venereol. 2015 May;95(5):632-3. doi: 10.2340/00015555-2001. No abstract available.

7.

Acral Mycosis Fungoides With Epidermal Microvesiculation Mucinosis.

Riveiro-Falkenbach E, Ruano Y, Garrido M, Ortiz-Romero PL, Rodríguez-Peralto JL.

Am J Dermatopathol. 2014 Jul 21. [Epub ahead of print]

PMID:
25051106
8.

Multisystemic Langerhans cell histiocytosis mimicking diffuse neonatal hemangiomatosis.

Rubio-González B, García-Bracamonte B, Ortiz-Romero PL, Postigo-Llorente C, Vanaclocha-Sebastián F.

Pediatr Dermatol. 2014 May-Jun;31(3):e87-9. doi: 10.1111/pde.12319. Epub 2014 Mar 3.

PMID:
24588084
9.

PLCG1 mutations in cutaneous T-cell lymphomas.

Vaqué JP, Gómez-López G, Monsálvez V, Varela I, Martínez N, Pérez C, Domínguez O, Graña O, Rodríguez-Peralto JL, Rodríguez-Pinilla SM, González-Vela C, Rubio-Camarillo M, Martín-Sánchez E, Pisano DG, Papadavid E, Papadaki T, Requena L, García-Marco JA, Méndez M, Provencio M, Hospital M, Suárez-Massa D, Postigo C, San Segundo D, López-Hoyos M, Ortiz-Romero PL, Piris MA, Sánchez-Beato M.

Blood. 2014 Mar 27;123(13):2034-43. doi: 10.1182/blood-2013-05-504308. Epub 2014 Feb 4.

10.

Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.

Servitje O, Muniesa C, Benavente Y, Monsálvez V, Garcia-Muret MP, Gallardo F, Domingo-Domenech E, Lucas A, Climent F, Rodriguez-Peralto JL, Ortiz-Romero PL, Sandoval J, Pujol RM, Estrach MT.

J Am Acad Dermatol. 2013 Sep;69(3):357-65. doi: 10.1016/j.jaad.2013.04.047. Epub 2013 Jun 21.

PMID:
23796549
11.

Hemophagocytic syndrome as a complication in a patient with Sézary syndrome.

Petiti-Martin G, Fuertes L, Villar-Buil M, Burgués-Calderón M, Vanaclocha F, Ortiz-Romero PL.

Int J Dermatol. 2013 Jun;52(6):733-4. doi: 10.1111/j.1365-4632.2011.05286.x. No abstract available.

PMID:
23679880
12.

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma.

Monsálvez V, Montes-Moreno S, Artiga MJ, Rodríguez ME, Espiridión BS, Lozano M, Fernández-de-Misa R, Rodríguez-Peralto JL, Piris MA, Ortíz-Romero PL.

Mod Pathol. 2013 Apr;26(4):617. doi: 10.1038/modpathol.2012.209. No abstract available.

13.

Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.

Fernández-Guarino M, Ortiz-Romero PL, Fernández-Misa R, Montalbán C.

Actas Dermosifiliogr. 2014 Jun;105(5):438-45. doi: 10.1016/j.ad.2012.10.021. Epub 2013 Mar 26. English, Spanish.

PMID:
23540593
14.

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

Odqvist L, Sánchez-Beato M, Montes-Moreno S, Martín-Sánchez E, Pajares R, Sánchez-Verde L, Ortiz-Romero PL, Rodriguez J, Rodríguez-Pinilla SM, Iniesta-Martínez F, Solera-Arroyo JC, Ramos-Asensio R, Flores T, Palanca JM, Bragado FG, Franjo PD, Piris MA.

Clin Cancer Res. 2013 May 1;19(9):2319-30. doi: 10.1158/1078-0432.CCR-12-3151. Epub 2013 Mar 27.

15.

TCR-γ expression in primary cutaneous T-cell lymphomas.

Rodríguez-Pinilla SM, Ortiz-Romero PL, Monsalvez V, Tomás IE, Almagro M, Sevilla A, Camacho G, Longo MI, Pulpillo Á, Diaz-Pérez JA, Montes-Moreno S, Castro Y, Echevarría B, Trébol I, Gonzalez C, Sánchez L, Otín AP, Requena L, Rodríguez-Peralto JL, Cerroni L, Piris MÁ.

Am J Surg Pathol. 2013 Mar;37(3):375-84. doi: 10.1097/PAS.0b013e318275d1a2.

PMID:
23348211
16.

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma.

Monsálvez V, Montes-Moreno S, Artiga MJ, Rodríguez ME, Sanchez-Espiridion B, Lozano M, Fernández-de-Misa R, Rodríguez-Peralto JL, Piris MA, Ortíz-Romero PL.

Mod Pathol. 2013 Feb;26(2):171-81. doi: 10.1038/modpathol.2012.149. Epub 2012 Aug 31. Erratum in: Mod Pathol. 2013 Apr;26(4):617. Espiridión, Beatriz S [corrected to Sanchez-Espiridion, Beatriz].

17.

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.

Martín-Sánchez E, Rodríguez-Pinilla SM, Sánchez-Beato M, Lombardía L, Domínguez-González B, Romero D, Odqvist L, García-Sanz P, Wozniak MB, Kurz G, Blanco-Aparicio C, Mollejo M, Alves FJ, Menárguez J, González-Palacios F, Rodríguez-Peralto JL, Ortiz-Romero PL, García JF, Bischoff JR, Piris MA.

Haematologica. 2013 Jan;98(1):57-64. doi: 10.3324/haematol.2012.068510. Epub 2012 Jul 16.

18.

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.

Peñate Y, Hernández-Machín B, Pérez-Méndez LI, Santiago F, Rosales B, Servitje O, Estrach T, Fernández-Guarino M, Calzado L, Acebo E, Gallardo F, Salar A, Izu R, Ortiz-Romero PL, Pujol RM, Fernández-de-Misa R.

Br J Dermatol. 2012 Jul;167(1):174-9. doi: 10.1111/j.1365-2133.2012.10902.x.

PMID:
22356294
19.

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, Olsen E, Kim YH, Dummer R, Pimpinelli N, Whittaker S, Hodak E, Cerroni L, Berti E, Horwitz S, Prince HM, Guitart J, Estrach T, Sanches JA, Duvic M, Ranki A, Dreno B, Ostheeren-Michaelis S, Knobler R, Wood G, Willemze R.

Blood. 2011 Oct 13;118(15):4024-35. doi: 10.1182/blood-2011-05-351346. Epub 2011 Aug 12. Review.

20.

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC; International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

J Clin Oncol. 2011 Jun 20;29(18):2598-607. doi: 10.1200/JCO.2010.32.0630. Epub 2011 May 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk